Decreased distant recurrence and preserved local control using dose dense induction weekly paclitaxel (P) and carboplatin (C) followed by concurrent paclitaxel, carboplatin and radiotherapy (CRT) in locally advanced head and neck squamous cell cancers (HN-SCC).

被引：0
|
作者：
Nadeem, A [1 ]
Desai, S [1 ]
Chougule, P [1 ]
Wanebo, H [1 ]
Ruhl, C [1 ]
Joyce, D [1 ]
Tarro, J [1 ]
Kennedy, T [1 ]
Ready, N [1 ]
机构：
[1] Brown Univ, Oncol Grp, Providence, RI 02912 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5545
引用
收藏
页码：499S / 499S
页数：1
相关论文
共 33 条
  • [1] Phase I/II study of induction weekly paclitaxel, ifosfamide and carboplatin (PIC) followed by chemoradiotherapy (CRT) in advanced head and neck squamous cell cancers (HN-SCC).
    Rathore, R
    Chougule, P
    Wanebo, H
    Nadeem, A
    Radie-Keane, K
    Sikov, W
    Negri, P
    Kennedy, T
    Ready, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 513S - 513S
  • [2] Weekly Paclitaxel and Carboplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Ready, Neal E.
    Rathore, Ritesh
    Johnson, Tirrell T.
    Nadeem, Ahmed
    Chougule, Prakash
    Ruhl, Charles
    Radie-Keane, Kathy
    Theall, Kathy
    Wanebo, Harold J.
    Marcello, Jennifer
    Kennedy, Teresa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (01): : 6 - 12
  • [3] A phase III study of concurrent radiotherapy with carboplatin of weekly paclitaxel in patients with advanced squamous cell head and neck cancer (SCHNC)
    Andreadis, C
    Sidiropoulos, J
    Vahtsevanos, K
    Thomaidis, J
    Destouni, E
    Kasfikis, D
    Mouratidou, D
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S172 - S172
  • [4] Induction cetuximab (C) followed by C, paclitaxel (P), carboplatin (CP) and concurrent radiation (RT) for locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Birnbaum, A. E.
    Johnson, T. T.
    Rathore, R.
    Khurshid, H.
    Puthawala, M.
    Keane, K. Radie
    Ruhl, C.
    Wanebo, H.
    Kennedy, T.
    Ready, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
    Haddad, R. I.
    Massarelli, E.
    Lee, J. J.
    Lin, H. Y.
    Hutcheson, K.
    Lewis, J.
    Garden, A. S.
    Blumenschein, G. R.
    William, W. N.
    Pharaon, R. R.
    Tishler, R. B.
    Glisson, B. S.
    Pickering, C.
    Gold, K. A.
    Johnson, F. M.
    Rabinowits, G.
    Ginsberg, L. E.
    Williams, M. D.
    Myers, J.
    Kies, M. S.
    Papadimitrakopoulou, V.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 471 - 477
  • [6] Phase II study of induction weekly paclitaxel, ifosfamide, and carboplatin (PIC) followed by chemoradiotherapy (CRT) in locally advanced head and neck squamous cell cancer (HNSCC): A Brown University Oncology Group Study (HN-86).
    Rathore, R
    Chougule, P
    Wanebo, H
    Theall, K
    Ruhl, C
    Nadeem, A
    Koness, J
    Oldenburg, N
    Kennedy, T
    Ready, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 514S - 514S
  • [7] PHASE II STUDY EVALUATING THE ADDITION OF CETUXIMAB TO THE CONCURRENT DELIVERY OF WEEKLY CARBOPLATIN, PACLITAXEL, AND DAILY RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMAS OF THE HEAD AND NECK
    Suntharalingam, Mohan
    Kwok, Young
    Goloubeva, Olga
    Parekh, Arti
    Taylor, Rodney
    Wolf, Jeffrey
    Zimrin, Ann
    Strome, Scott
    Ord, Robert
    Cullen, Kevin J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : 1845 - 1850
  • [8] A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)
    Grover, Surbhi
    Mitra, Nandita
    Wan, Fei
    Lukens, John N.
    Sharma, Sonam
    Bauman, Jessica
    Masroor, Farzad
    Cohen, Roger B.
    Desai, Arati
    Algazy, Kenneth
    Alonso-Basanta, Michelle
    Ahn, Peter
    Teo, Boon-Keng Kevin
    Chalian, Ara A.
    Weinstein, Gregory S.
    O'Malley, Bert W., Jr.
    Lin, Alexander
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (05): : 522 - 527
  • [9] Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    McClurkan, S
    Gray, JR
    Stroup, SL
    Burris, HA
    Yardley, DA
    Bradof, JE
    Yost, K
    Ellis, JK
    Greco, FA
    CANCER JOURNAL, 2002, 8 (04): : 311 - 321
  • [10] CAPRA: Safety, efficacy, and translational biomarkers of weekly everolimus, carboplatin, and paclitaxel as induction therapy for locally advanced head and neck squamous cell carcinoma (HNSCC)
    Raymond, Eric
    Le Tourneau, Christophe
    Gatineau, Michel
    Delord, Jean-Pierre
    Fayette, Jerome
    Dreyer, Chantal
    Tijeras-Raballand, Annemilai
    Albert, Sebastien
    Granier, Muriel
    Chibaudel, Benoist
    Hadengue, Alexandra
    Aissat, Nasredine
    Slimane, Khemaies
    Faivre, Sandrine J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
1234